Integrating social nutrition principles into the treatment of steatotic liver disease

Dana Ivancovsky-Wajcman; Paul N Brennan; Christopher J Kopka; Shira Zelber-Sagi; Zobair M Younossi; Alina M Allen; Karen R Flórez; Jeffrey V Lazarus

doi:10.1038/s43856-023-00398-3

Integrating social nutrition principles into the treatment of steatotic liver disease

Commun Med (Lond). 2023 Nov 10;3(1):165. doi: 10.1038/s43856-023-00398-3.

Authors

Dana Ivancovsky-Wajcman¹, Paul N Brennan^{2

3}, Christopher J Kopka⁴, Shira Zelber-Sagi^{3

5}, Zobair M Younossi^{3

6}, Alina M Allen⁷, Karen R Flórez⁸, Jeffrey V Lazarus^{9

10

11}

Affiliations

¹ Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
² Medical Research Institute, Ninewells Hospital, University of Dundee, Dundee, UK.
³ The Global NASH Council, Washington, DC, USA.
⁴ Independent researcher, Ponte de Lima, Portugal.
⁵ School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel.
⁶ Obesity Research Program, Inova Health System, Falls Church, VA, USA.
⁷ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
⁸ CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA.
⁹ Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain. Jeffrey.Lazarus@sph.cuny.edu.
¹⁰ The Global NASH Council, Washington, DC, USA. Jeffrey.Lazarus@sph.cuny.edu.
¹¹ CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA. Jeffrey.Lazarus@sph.cuny.edu.

Abstract

Current treatment of metabolic dysfunction-associated steatotic liver disease focuses on adjusting patients’ lifestyles, including promoting weight loss and physical activity. Here, we suggest adopting a holistic preventive hepatology approach encompassing social nutrition, social prescribing and broader societal changes to facilitate individuals’ engagement with behavioural modifications.